28 януари 2012, 01:49
- акушерство и
гинекология - анестезиология
и реанимация - биотехнологии
- гастроентеро-
логия - дерматология
- диетология
- ендокринология
- естетична
медицина - кардиология
- неврология
- онкология
- оториноларин-
гология - офталмология
- педиатрия
и неонатология - пулмология
и фтизиатрия - рентгенология
- стоматология
- урология
- фармация
- физиотерапия
- хирургия
The Swiss drug maker Novartis has gained the approval of American regulators for its multiple sclerosis pill Gilenya, putting it ahead of the German rival Merck in the race to be first with an oral treatment in the United States.
The Food and Drug Administration’s backing was...
Abbott Laboratories is buying the pharmaceutical operations of its partner Solvay, saying that it is gaining “a large and complementary portfolio” of products and “a significant presence in key global emerging markets”.
Under the terms of the deal, Abbott is paying 4.5 billion...
Taking high dose of active forms of Vitamin D is found to reduce risk of falling for those over age 65. A new study, published in BMJ shows that taking 700 to 1000IU of vitamin D2 daily reduces fall risk among elders by nineteen percent.
Reducing fall risk among older people is...
- рекламни акценти